The effect of some psychoactive drugs on central monoamine neurons.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002707:Chlordiazepoxide / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000096:biosynthesis*; D000431:Ethanol / Q000494:pharmacology; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009411:Nerve Endings / Q000187:drug effects; D009474:Neurons / Q000187:drug effects*; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis / Q000096:biosynthesis*; D010424:Pentobarbital / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012701:Serotonin / Q000032:analysis / Q000096:biosynthesis*; D014443:Tyrosine / Q000494:pharmacology
D000928:Antidepressive Agents; D011955:Receptors, Drug; D012701:Serotonin; D000431:Ethanol; D014443:Tyrosine; D002707:Chlordiazepoxide; D000661:Amphetamine; D006899:Mixed Function Oxygenases; D010424:Pentobarbital; D009526:Nialamide; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine; D010633:Phenmetrazine